Abstract 1424: Angioplasty or Stenting? Contemporary Nationwide Outcomes of Cervical Carotid Treatment During Thrombectomy
Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)
DOI: 10.1161/svi270000_1424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von A. Patel und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The optimal management of the cervical carotid lesion during mechanical thrombectomy (MT) remains uncertain. Carotid stenting provides definitive revascularization but generally requires antiplatelet therapy, whereas angioplasty alone avoids permanent device placement but may require subsequent revascularization. Prior multicenter and meta-analytic studies associated stenting with improved reperfusion or functional outcomes without a clear increase in symptomatic intracranial hemorrhage. Whether these findings translate to contemporary, nationwide practice remains uncertain. We compared in-hospital outcomes of same-day cervical carotid angioplasty alone versus stenting using the 2023 NIS.
Method
We analyzed the 2023 National Inpatient Sample. Adults with acute ischemic stroke undergoing mechanical thrombectomy were identified using audited ICD-10-CM/PCS definitions. Procedure-day variables classified same-day cervical carotid angioplasty alone versus stenting. The primary outcome was coded intracranial hemorrhage; secondary outcomes included mortality, routine home discharge, length of stay, and hospital charges. Survey-weighted models adjusted for demographics, vascular comorbidities, intravenous thrombolysis, transfer status, and teaching-hospital status. An intracranial-thrombectomy-only cohort was examined as a sensitivity analysis.
Result
The cohort included 680 admissions: 194 angioplasty alone and 486 carotid stenting, representing approximately 3,400 weighted hospitalizations. Intracranial hemorrhage occurred in 20.6% versus 27.6% (aOR 1.44, 95% CI 0.96-2.16; p=0.080). Mortality occurred in 9.8% versus 14.6%, with higher adjusted odds after stenting (aOR 1.80, 95% CI 1.05-3.08; p=0.033). Routine home discharge, length of stay, and hospital charges did not differ significantly. The intracranial thrombectomy only sensitivity analysis yielded directionally similar findings.
Discussion
Carotid stenting was associated with higher adjusted odds of in-hospital mortality compared with angioplasty alone, while intracranial hemorrhage and other in-hospital outcomes did not differ significantly. Because the NIS lacks information on stroke severity, lesion anatomy, procedural success, and antiplatelet therapy, residual confounding and treatment selection may explain the mortality association. Prospective studies with clinically adjudicated outcomes are needed..
Zitieren
APA
Patel, A., & Gomez, R. (2026). Abstract 1424: Angioplasty or Stenting? Contemporary Nationwide Outcomes of Cervical Carotid Treatment During Thrombectomy. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1424
Vancouver
Patel A, Gomez R. Abstract 1424: Angioplasty or Stenting? Contemporary Nationwide Outcomes of Cervical Carotid Treatment During Thrombectomy. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1424
BibTeX
@article{Patel2026,
author = {Patel, A. and Gomez, R.},
title = {Abstract 1424: Angioplasty or Stenting? Contemporary Nationwide Outcomes of Cervical Carotid Treatment During Thrombectomy},
journal = {Stroke: Vascular and Interventional Neurology},
year = {2026},
volume = {6},
number = {Suppl_1},
doi = {10.1161/svi270000_1424}
}
EUVIMED